Lupus anticoagulant positivity in insulin dependent diabetic patients: an additional risk factor in the pathogenesis of diabetic retinopathy?
- Cristiano Giustia,
- Riccardo Schiaffinib,
- Daniela Boscob,
- Paolo Ciampalinib,
- Antonio Pantaleob,
- Enzo M Vingoloa,
- Patrizia Gargiulob
- Cristiano Giusti, MD, Via Cassia 1280 (Pal B1, int 10), I-00189 Rome, Italy crigiust{at}tin.it
- Accepted 13 January 2000
Abstract
AIMS To investigate whether lupus anticoagulant (LA) positivity, a marker of endothelial dysfunction, might be relevant to the pathogenesis of diabetic retinopathy (DR).
METHODS 32 IDDM patients were examined for LA, fibrinogen, prothrombin (PT), PTT, prothrombin degradation products (F1+2), and activated protein C (APC).
RESULTS APC decreased and F1+2 increased significantly in LA positive but not in LA negative patients; 60% of LA positive and 18% of LA negative subjects had DR. PT, PTT, and fibrinogen levels were insignificant.
CONCLUSION These preliminary findings suggest that LA positivity could represent an additional risk factor for DR, acting as a link between the immunological and haemostatic systems.








